Universal Beteiligungs und Servicegesellschaft mbH Sells 14,457 Shares of Encompass Health Corporation $EHC

Universal Beteiligungs und Servicegesellschaft mbH lessened its stake in Encompass Health Corporation (NYSE:EHC) by 13.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 92,965 shares of the company’s stock after selling 14,457 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Encompass Health were worth $11,808,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of EHC. Ethic Inc. bought a new position in Encompass Health in the 3rd quarter valued at approximately $1,272,000. Belpointe Asset Management LLC purchased a new position in shares of Encompass Health in the second quarter worth $210,000. Marshall Wace LLP bought a new position in shares of Encompass Health during the second quarter valued at $34,719,000. Bahl & Gaynor Inc. boosted its position in shares of Encompass Health by 14.8% during the second quarter. Bahl & Gaynor Inc. now owns 288,226 shares of the company’s stock valued at $35,345,000 after buying an additional 37,161 shares during the last quarter. Finally, Braun Stacey Associates Inc. increased its holdings in Encompass Health by 9.3% in the 3rd quarter. Braun Stacey Associates Inc. now owns 223,673 shares of the company’s stock worth $28,411,000 after buying an additional 18,967 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on EHC shares. Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. UBS Group raised their target price on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday, October 2nd. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Barclays increased their price target on Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. Finally, Raymond James Financial raised Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, Encompass Health has a consensus rating of “Buy” and a consensus target price of $142.86.

Encompass Health Trading Down 1.0%

Shares of EHC stock opened at $98.36 on Friday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.14 and a quick ratio of 1.14. The company has a market cap of $9.90 billion, a price-to-earnings ratio of 18.59, a PEG ratio of 1.58 and a beta of 0.74. Encompass Health Corporation has a 1 year low of $92.53 and a 1 year high of $127.99. The firm has a fifty day moving average price of $107.79 and a 200-day moving average price of $115.60.

Encompass Health (NYSE:EHC) last released its earnings results on Wednesday, October 29th. The company reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.04. Encompass Health had a return on equity of 17.84% and a net margin of 9.33%.The company had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.48 billion. During the same period in the previous year, the business earned $1.03 earnings per share. Encompass Health’s quarterly revenue was up 9.4% compared to the same quarter last year. As a group, equities analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.